Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
2 other identifiers
interventional
100
1 country
1
Brief Summary
The primary purpose of this study is to observe reduced access site complications in patients with heavily calcified common femoral arteries requiring Transcatheter Aortic Valve Replacement (TAVR)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2025
CompletedFirst Posted
Study publicly available on registry
October 3, 2025
CompletedStudy Start
First participant enrolled
October 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 4, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 4, 2026
October 3, 2025
August 1, 2025
1.1 years
August 21, 2025
September 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate for contrast extravasation post closure of femoral artery at the end of the procedure
Immediately post-procedure
Secondary Outcomes (15)
Determine need for Vascular surgery consultation
During hospital stay (Day 0-3)
If vascular complication, was PTA, stenting, or open surgery used
During hospital stay (Day 0-3)
Number of perclose devices used to close the femoral artery access site
During procedure (Day 0)
Determine presence of other vascular complications I.e. bleeding, hematoma, emboli etc
Within 3 days post-procedure
Change in Hemoglobin
Day 0 to Day 3 post-procedure
- +10 more secondary outcomes
Study Arms (2)
Shockwave model (M5) Intravascular Lithotripsy (IVL)
EXPERIMENTALPatients will be treated with the Shockwave M5 Intravascular Lithotripsy (IVL) device prior to femoral artery access using the modified Seldinger technique
Standard femoral access
ACTIVE COMPARATORPatients will receive standard femoral artery access via the modified Seldinger approach without utilizing intravascular lithotripsy in heavily calcified femoral arteries
Interventions
The Shockwave M5 IVL Catheter is a balloon catheter designed to modify calcified arterial plaque using intravascular lithotripsy prior to vascular access
Standard of care for femoral access in patients with calcified femoral arteries
Eligibility Criteria
You may qualify if:
- \>18 years of age
- Patient with a diagnosis of severe aortic stenosis undergoing TAVR
- Participants must be able to read and understand study procedures
- Willing to participate and sign an ICF
- Patients with \> 90-degree arc of calcium at the large bore access site per CT documentation
You may not qualify if:
- Unable to understand study procedures
- Unwilling to give consent
- Patients with cognitive impairments that can affect their ability to give consent
- Unfavorable calcium distribution of femoral artery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Tennessee Medical Center
Knoxville, Tennessee, 37920, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2025
First Posted
October 3, 2025
Study Start
October 4, 2025
Primary Completion (Estimated)
November 4, 2026
Study Completion (Estimated)
November 4, 2026
Last Updated
October 3, 2025
Record last verified: 2025-08